Amyloid beta-peptide aggregation. What does it result in and how can it be prevented?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Frontiers in Bioscience

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2741/3335PMID 19273157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009influential reference
• Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation

  2008cited by this paper
• Small-molecule aggregates inhibit amyloid polymerization.

  2008cited by this paper
• Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease

  2008cited by this paper
• Aβ42 Mutants with Different Aggregation Profiles Induce Distinct Pathologies in Drosophila

  2008cited by this paper
• Aggregator compounds confound amyloid fibrillization assay.

  2008cited by this paper
• Regulated Intramembrane Proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b*

  2008cited by this paper
• Potent memapsin 2 (beta-secretase) inhibitors: design, synthesis, protein-ligand X-ray structure, and in vivo evaluation.

  2008cited by this paper
• Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct*

  2007cited by this paper
• Systematic In Vivo Analysis of the Intrinsic Determinants of Amyloid β Pathogenicity

  2007cited by this paper
• The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species.

  2007cited by this paper
• The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures

  2007cited by this paper
• Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis

  2007cited by this paper
• Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization.

  2007cited by this paper
• Alzheimer disease: amyloidogenesis, the presenilins and animal models.

  2007cited by this paper
• Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.

  2007cited by this paper
• A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation.

  2007cited by this paper
• Oral administration of a potent and selective non‐peptidic BACE‐1 inhibitor decreases β‐cleavage of amyloid precursor protein and amyloid‐β production in vivo

  2007cited by this paper
• Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels

  2007cited by this paper
• Positioning of the Alzheimer Aβ(1–40) peptide in SDS micelles using NMR and paramagnetic probes

  2007cited by this paper
• Solution state characterization of amyloid beta-derived diffusible ligands.

  2006cited by this paper
• Poly-N-methylated alpha-peptides: synthesis and X-ray structure determination of beta-strand forming foldamers.

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

  2006cited by this paper
• Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives.

  2006cited by this paper
• Poly-N-methylated α-peptides: synthesis and X-ray structure determination of β-strand forming foldamers

  2006cited by this paper
• A&bgr; Species Removal After A&bgr;42 Immunization

  2006cited by this paper
• Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers

  2006cited by this paper
• 100 Years and Counting: Prospects for Defeating Alzheimer's Disease

  2006cited by this paper
• Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model

  2006cited by this paper
• Solution State Characterization of Amyloid β-Derived Diffusible Ligands

  2006cited by this paper
• Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease

  2005cited by this paper
• Functional Amyloid Formation within Mammalian Tissue

  2005cited by this paper
• Globular amyloid b-peptide 1 ) 42 oligomer ) a homogenous and stable neuropathological protein in Alzheimer ’ s disease

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-beta(1-42) fibrils.

  2005cited by this paper
• Invertebrate models of Alzheimer's disease

  2005cited by this paper
• Stimulatory and inhibitory effects of alkyl bromide surfactants on beta-amyloid fibrillogenesis.

  2005cited by this paper
• The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.

  2005cited by this paper
• Structures for amyloid fibrils

  2005cited by this paper
• Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.

  2005cited by this paper
• Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo*

  2005influential reference
• Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

  2005cited by this paper
• Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-β(1–42) fibrils

  2005influential reference
• Nicotine attenuates β‐amyloid peptide‐induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures

  2004cited by this paper
• Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation.

  2004cited by this paper
• Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation*

  2004cited by this paper
• Immunotherapy for Alzheimer's disease

  2004cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

  2003cited by this paper
• Slow Cognitive Decline in Alzheimer’s Disease

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss

  2003cited by this paper
• Self-assembly of Abeta(1-42) into globular neurotoxins.

  2003cited by this paper
• Reconstitution of γ-secretase activity

  2003cited by this paper
• Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

  2003cited by this paper
• A Protein-Chameleon: Conformational Plasticity of α-Synuclein, a Disordered Protein Involved in Neurodegenerative Disorders

  2003cited by this paper
• A specific mechanism of nonspecific inhibition.

  2003cited by this paper
• Amyloid -protein (A) assembly: A40 and A42 oligomerize through distinct pathways

  2003cited by this paper
• Reconstitution of gamma-secretase activity.

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation.

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• A novel compound RS-0466 reverses beta-amyloid-induced cytotoxicity through the Akt signaling pathway in vitro.

  2002influential reference
• Neurodegenerative disease: Amyloid pores from pathogenic mutations

  2002cited by this paper
• APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos

  2002cited by this paper
• A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.

  2002influential reference
• Intramembrane proteolysis controls diverse signalling pathways throughout evolution.

  2002cited by this paper
• Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Abeta1-40 fibrillogenesis.

  2002cited by this paper
• A novel β‐sheet breaker, RS‐0406, reverses amyloid β‐induced cytotoxicity and impairment of long‐term potentiation in vitro

  2002influential reference
• A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro.

  2002cited by this paper
• Climate change (Communication arising): Recent temperature trends in the Antarctic

  2002cited by this paper
• aph-1 and pen-2 Are Required for Notch Pathway Signaling, γ-Secretase Cleavage of βAPP, and Presenilin Protein Accumulation

  2002cited by this paper
• A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

  2002cited by this paper
• BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• BACE1 is the major β-secretase for generation of Aβ peptides by neurons

  2001cited by this paper
• Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

  2001cited by this paper
• Transgenic mouse models of Alzheimer's disease.

  2001cited by this paper
• Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy.

  2001cited by this paper
• Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation

  2001cited by this paper
• Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.

  2001cited by this paper
• A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

  2001cited by this paper
• NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox).

  2001influential reference
• Inositol Stereoisomers Stabilize an Oligomeric Aggregate of Alzheimer Amyloid β Peptide and Inhibit Aβ-induced Toxicity*

  2000cited by this paper
• Alzheimer's amyloid fibrils: structure and assembly.

  2000cited by this paper
• The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain.

  2000cited by this paper
• Inhibition of Toxicity in the β-Amyloid Peptide Fragment β-(25–35) Using N-Methylated Derivatives

  2000cited by this paper
• Transgenic mouse models of Alzheimer's disease.

  2000cited by this paper
• Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor.

  2000cited by this paper
• Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

  2000cited by this paper
• Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes.

  2000cited by this paper
• Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.

  2000influential reference
• Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity.

  2000cited by this paper
• Amyloid, prions, and other protein aggregates

  2000cited by this paper
• Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.

  2000cited by this paper

• Hydrophobic C-Terminal Peptide Analog Aβ31-41 Protects the Neurons from Aβ-Induced Toxicity.

  2024cites this paper
• Neuroprotective Action of Polyphenols and Phenolic Compounds: An Overview

  2023cites this paper
• Side-Chain Proline-Based Polymers as Effective Inhibitors for In Vitro Aggregation of Insulin.

  2020cites this paper
• Identification of a New Function of Cardiovascular Disease Drug 3-Morpholinosydnonimine Hydrochloride as an Amyloid-β Aggregation Inhibitor

  2017cites this paper
• “The Greatness of the Smallest Ones”: The Most Valuable Attributes of Flies and Worms for the Study of Neurodegeneration

  2015cites this paper
• Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights

  2014cites this paper
• Diaryl hydrazones as multifunctional inhibitors of amyloid self-assembly.

  2013cites this paper
• Mutation in E1, the Ubiquitin Activating Enzyme, Reduces Drosophila Lifespan and Results in Motor Impairment

  2013cites this paper
• Modulation of amyloid-β 1-42 structure and toxicity by proline-rich whey peptides.

  2013cites this paper
• Peptides for Therapy and Diagnosis of Alzheimer’s Disease

  2012cites this paper
• Methods to evaluate the inhibition of TTR fibrillogenesis induced by small ligands.

  2012cites this paper
• Structure–Activity Relationships of Organofluorine Inhibitors of β‐Amyloid Self‐Assembly

  2012cites this paper
• Protein‐Polyelectrolyte Complexes. How to Suppress Thermoaggregation without Noticeable Denaturing of the Protein?

  2012cites this paper
• Synthetic–Biological Hybrid Polymers

  2012cites this paper
• Pathogenic Protein Strains as Diagnostic and Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Efficacy of Multifunctionalized Saccharide Constructs for the Attenuation of Amyloid-beta Toxicity

  2012cites this paper
• Soluble polyelectrolyte complexes of biopolymers

  2012cites this paper
• An Alzheimer's disease‐relevant presenilin‐1 mutation augments amyloid‐beta‐induced oligodendrocyte dysfunction

  2011cites this paper
• Can molecular dynamics simulations assist in design of specific inhibitors and imaging agents of amyloid aggregation? Structure, stability and free energy predictions for amyloid oligomers of VQIVYK, MVGGVV and LYQLEN

  2011cites this paper
• Detection of Soluble Amyloid-β Oligomers and Insoluble High-Molecular-Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer's Disease

  2011cites this paper
• Yeast as a Model for Studying A Aggregation, Toxicity and Clearance

  2011cites this paper
• Self-assembly Of Amyloid Aggregates Simulated With Molecular Dynamics

  2011cites this paper
• Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's Disease transgenic mice.

  2010cites this paper
• Agent-based modeling for the 2D molecular self-organization of realistic molecules.

  2010cites this paper
• Structural changes of a protein bound to a polyelectrolyte depend on the hydrophobicity and polymerization degree of the polyelectrolyte

  2010cites this paper
• Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific binding.

  2010cites this paper
• Poly-N-methylated amyloid beta-peptide (Abeta) C-terminal fragments reduce Abeta toxicity in vitro and in Drosophila melanogaster.

  2009cites this paper
• Fluorescence and mass spectrometry studies of the interaction between naproxen and synthetic pseudopeptidic models in organic media

  2009cites this paper
• Strategies exploiting functions and self-assembly properties of bioconjugates for polymer and materials sciences

  2009cites this paper
• First principles determination of structural, electronic and lattice dynamical properties of a model dipeptide molecular crystal

  2009cites this paper
• Neurodegenerative disorders and nanoformulated drug development.

  2009cites this paper
• Sialic Acid Conjugated Chitosan for the Attenuation of Amyloid-beta Toxicity

  2009cites this paper